Authors: Reginster, JY Christiansen, C Roux, C Fechtenbaum, J Rouillon, A Tou, KP

Citation: Jy. Reginster et al., Intermittent cyclic tiludronate in the treatment of osteoporosis, OSTEOPOR IN, 12(3), 2001, pp. 169-177

Authors: Hayoz, D Bizzini, G Noel, B Depairon, M Burnier, M Fauveau, C Rouillon, A Brouard, R Brunner, HR

Citation: D. Hayoz et al., Effect of SR 49059, a V1a vasopressin receptor antagonist, in Raynand's phenomenon, RHEUMATOLOG, 39(10), 2000, pp. 1132-1138

Authors: Patton, EE Peyraud, C Rouillon, A Surdin-Kerjan, Y Tyers, M Thomas, D

Citation: Ee. Patton et al., SCFMet30-mediated control of the transcriptional activator Met4 is required for the G(1)-S transition, EMBO J, 19(7), 2000, pp. 1613-1624

Authors: Rouillon, A Barbey, R Patton, EE Tyers, M Thomas, D

Citation: A. Rouillon et al., Feedback-regulated degradation of the transcriptional activator Met4 is triggered by the SCFMet30 complex, EMBO J, 19(2), 2000, pp. 282-294

Authors: Rouillon, A Surdin-Kerjan, Y Thomas, D

Citation: A. Rouillon et al., Transport of sulfonium compounds. Characterization of the S-adenosylmethionine and S-methylmethionine permeases from the yeast Saccharomyces cerevisiae (vol 274, pg 28096, 1999), J BIOL CHEM, 274(47), 1999, pp. 33825-33825

Authors: Rouillon, A Surdin-Kerjan, Y Thomas, D

Citation: A. Rouillon et al., Transport of sulfonium compounds - Characterization of the S-adenosylmethionine and S-methylmethionine permeases from the yeast Saccharomyces cerevisiae, J BIOL CHEM, 274(40), 1999, pp. 28096-28105